MagSIL (NucliSENS easyMAG Magnetic Silica), Product Usage: The NucliSENS® easyMAG® system is an in vitro diagnostic medical device and is intended for the automated isolation (purification and concentration) of total nucleic acids (RNA/DNA) from biological specimens.
Published January 25, 2017 · Recall initiated: November 23, 2016
Summary
FDA records medical device Class I recall Z-0976-2017, published January 25, 2017 and initiated November 23, 2016. Recalling firm: BioMerieux SA; Status: Terminated; Reported quantity: 3723 units in total; Lot: Reference number: 280133, Lot numbers: Z017KA1MS, Z017KB1MS, Z017LE1MS, Z017MA1MS, Z017NA1MS, Z017NB1MS, Z017NC1MS and Z017ND1MS. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A drift of the performance with the BK test (BK virus, worst case application) was observed for some silica batches of Magnetic Silica (MagSil). This is the same issue as in recall Z-2342-2016.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioMerieux SA
- Distributor
- Worldwide distribution. US Nationwide; BioMerieux Subsidiaries in: Argentina, Austria, Australia, Brazil, Canada, Switzerland, Chile, Colombia, Czech republic, Germany, Spain, France United Kingdom, Greece, China, Hungary, India, Italy, Japan, South Korea, Netherlands, Poland, Portugal, Russia Fed., Sweden, Singapore, Thailand, Turkey, South Africa; Distributors in: Peru, Kenya, Morocco, Serbia, Romania, Uruguay, Latvia, Dutch Antilles, Israel, Georgia, Armenia, Malaysia, Belarus and Direct Customers in: Togo, Djibouti, Burkina Faso, Mongolia, Zimbabwe, Uganda and Iraq.
- Lot
- Reference number: 280133, Lot numbers: Z017KA1MS, Z017KB1MS, Z017LE1MS, Z017MA1MS, Z017NA1MS, Z017NB1MS, Z017NC1MS and Z017ND1MS.
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- France
Related recalls
- FDAEMAG system Model/Catalog Number: 418591/418591U Product Description: Nucleic acid sample preparationNovember 4, 2026
- FDAMYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission ofAugust 18, 2021
- FDAVIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, France. For use on theJuly 4, 2018
- FDAThe VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinicalJune 20, 2018
- FDAHalo One 5F Introducer Sheath 90 cm Product Code: HAL590 Product Usage: The Halo One Thin-Walled GuidingJanuary 25, 2017
- FDANucliSENS magnetic extraction reagents, For in vitro diagnostic use, Product Usage: NucliSENS miniMAG® isJanuary 25, 2017
Questions about this recall
Was MagSIL (NucliSENS easyMAG Magnetic Silica), Product Usage: The NucliSENS® easyMAG® system is an in vitro diagnostic medical device and is intended for the automated isolation (purification and concentration) of total nucleic acids (RNA/DNA) from biological specimens. recalled?
Yes. FDA published recall Z-0976-2017 on January 25, 2017. Reported hazard: A drift of the performance with the BK test (BK virus, worst case application) was observed for some silica batches of Magnetic Silica (MagSil). This is the same issue as in recall Z-2342-2016.
What should I do if I have this product?
Voluntary: Firm initiated · Letter